We are live on
!
Find out more
Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$52.8B
1-Year Est. Return
58.98%
This Fund
S&P 500
This Quarter
Est. Return
+8.16%
1 Year Est. Return
+58.98%
3 Year Est. Return
+167.96%
5 Year Est. Return
+202.28%
10 Year Est. Return
+627.19%
AUM
$23.2B
AUM Growth
+$1.79B
(+8.3%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
2.2%
Top 10 Holdings %
Top 10 Hldgs %
23.34%
Holding
1,754
New
402
Increased
609
Reduced
482
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manulife Financial
MFC
|
+$123M |
| 2 |
Canadian Imperial Bank of Commerce
CM
|
+$112M |
| 3 |
CSX Corp
CSX
|
+$87.3M |
| 4 |
Zoetis
ZTS
|
+$84.5M |
| 5 |
Scotiabank
BNS
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$127M |
| 2 |
Merck
MRK
|
+$121M |
| 3 |
Toronto Dominion Bank
TD
|
+$106M |
| 4 |
Shopify
SHOP
|
+$82.4M |
| 5 |
Nutrien
NTR
|
+$74.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Financials | 21.49% |
| 3 | Industrials | 12.24% |
| 4 | Energy | 10.78% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Pacific Biosciences
PACB
$357M
| $555K | ﹤0.01% |
+148,046
| New | +$867K |
|
1077
AMERISAFE
AMSF
$504M
| $554K | ﹤0.01% |
+11,033
| New | +$548K |
|
1078
Western New England Bancorp
WNEB
$282M
| $553K | ﹤0.01% |
72,124
-8,017
| -10% | -$66.6K |
|
1079
Amphenol
APH
$204B
| $550K | ﹤0.01% |
+9,536
| New | +$500K |
|
|
DADA
1080
DELISTED
Dada Nexus
DADA
| $547K | ﹤0.01% |
266,818
+119,080
| +81% | +$255K |
|
1081
Marathon Petroleum
MPC
$100B
| $544K | ﹤0.01% |
2,700
-68,876
| -96% | -$11.8M |
|
1082
Parker-Hannifin
PH
$134B
| $542K | ﹤0.01% |
976
+156
| +19% | +$79.3K |
|
|
CBIO
1083
Crescent Biopharma
CBIO
$618M
| $542K | ﹤0.01% |
1,808
+374
| +26% | +$112K |
|
1084
Nektar Therapeutics
NKTR
$2.57B
| $536K | ﹤0.01% |
38,270
+5,155
| +16% | +$54K |
|
1085
Cogent Communications
CCOI
$530M
| $536K | ﹤0.01% |
+8,202
| New | +$599K |
|
1086
Health Catalyst
HCAT
$132M
| $534K | ﹤0.01% |
70,962
+12,545
| +21% | +$115K |
|
1087
Jakks Pacific
JAKK
$294M
| $534K | ﹤0.01% |
21,631
-8,864
| -29% | -$268K |
|
1088
Mercantile Bank Corp
MBWM
$1.06B
| $532K | ﹤0.01% |
13,809
+8,137
| +143% | +$310K |
|
|
ALPN
1089
DELISTED
Alpine Immune Sciences Inc
ALPN
| $529K | ﹤0.01% |
13,357
+1,448
| +12% | +$42.7K |
|
1090
Magnachip Semiconductor
MX
$137M
| $526K | ﹤0.01% |
94,304
+16,416
| +21% | +$105K |
|
1091
Hawaiian Electric Industries
HE
$2.04B
| $525K | ﹤0.01% |
+46,577
| New | +$592K |
|
|
SLCA
1092
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $525K | ﹤0.01% |
+42,274
| New | +$473K |
|
1093
Douglas Dynamics
PLOW
$967M
| $525K | ﹤0.01% |
+21,747
| New | +$550K |
|
1094
Willdan Group
WLDN
$1.29B
| $524K | ﹤0.01% |
18,068
+7,185
| +66% | +$156K |
|
1095
Moody's
MCO
$84.6B
| $521K | ﹤0.01% |
+1,325
| New | +$511K |
|
1096
Clover Health Investments
CLOV
$2.38B
| $518K | ﹤0.01% |
652,990
-176,951
| -21% | -$161K |
|
1097
Janus International
JBI
$686M
| $516K | ﹤0.01% |
34,130
+13,189
| +63% | +$192K |
|
|
SEE
1098
DELISTED
Sealed Air
SEE
| $514K | ﹤0.01% |
13,814
-5,610
| -29% | -$201K |
|
|
PBPB
1099
DELISTED
Potbelly
PBPB
| $513K | ﹤0.01% |
42,390
-10,853
| -20% | -$136K |
|
1100
Shell
SHEL
$248B
| $511K | ﹤0.01% |
7,624
-267
| -3% | -$17.1K |
|
Similar funds
SCP
Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2024 Portfolio in Review
As of Q1 2024, Connor, Clark & Lunn Investment Management (CC&L) held 1,754 positions worth $23.2B, up 8.3% from $21.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2024 filing shows 402 new, 609 increased, 482 reduced and 253 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 1,263,400 shares worth $51.9M. The largest sale was Walt Disney, an estimated $127M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2024 buy was iShares MSCI Emerging Markets ETF: 1,263,400 shares worth $51.9M.
- Connor, Clark & Lunn Investment Management (CC&L) added most to Manulife Financial in Q1 2024, an estimated $123M increase.
- Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2024 reduction was Walt Disney, cutting an estimated $127M.
- Connor, Clark & Lunn Investment Management (CC&L) fully exited Check Point Software Technologies in Q1 2024, selling an estimated $32.7M.
- Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 23% of its $23.2B portfolio in Q1 2024.
- Connor, Clark & Lunn Investment Management (CC&L) opened 402 new positions and closed 253 in Q1 2024.
- Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 8.3% quarter-over-quarter to $23.2B.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2024, filed 9 May 2024.